Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.
Rheumatol Int. 2018 Jun;38(6):935-947. doi: 10.1007/s00296-018-4005-5. Epub 2018 Mar 21.
Rheumatol Int. 2018.
PMID: 29564549
Free PMC article.
Review.
Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis.
Fakhouri W, Sapin C, Holzkaemper T, de la Torre I.
Fakhouri W, et al. Among authors: holzkaemper t.
Adv Ther. 2021 May;38(5):2747-2749. doi: 10.1007/s12325-021-01641-w. Epub 2021 Mar 20.
Adv Ther. 2021.
PMID: 33742363
Free PMC article.
No abstract available.
Item in Clipboard
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis.
Reich K, Conrad C, Kristensen LE, Smith SD, Puig L, Rich P, Sapin C, Holzkaemper T, Koppelhus U, Schuster C.
Reich K, et al. Among authors: holzkaemper t.
J Dermatolog Treat. 2022 May;33(3):1652-1660. doi: 10.1080/09546634.2021.1892024. Epub 2021 Mar 1.
J Dermatolog Treat. 2022.
PMID: 33641593
Item in Clipboard
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.
Egeberg A, Kristensen LE, Puig L, Rich P, Smith SD, Garrelts A, See K, Holzkaemper T, Fotiou K, Schuster C.
Egeberg A, et al. Among authors: holzkaemper t.
J Dermatolog Treat. 2023 Dec;34(1):2263108. doi: 10.1080/09546634.2023.2263108. Epub 2023 Oct 2.
J Dermatolog Treat. 2023.
PMID: 37781881
Free article.
Item in Clipboard
Ixekizumab im Vergleich zu Fumarsäureestern und Methotrexat bei der Behandlung der Nagelpsoriasis bei Patienten mit mittelschwerer bis schwerer Psoriasis: Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis.
Augustin M, Mrowietz U, Willsmann-Theis D, Gerdes S, Fotiou K, Schuster C, Mert C, Holzkaemper T, Behrens F, Pinter A.
Augustin M, et al. Among authors: holzkaemper t.
J Dtsch Dermatol Ges. 2024 Feb;22(2):278-282. doi: 10.1111/ddg.15292_g.
J Dtsch Dermatol Ges. 2024.
PMID: 38361190
No abstract available.
Item in Clipboard
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.
Deodhar A, Blauvelt A, Lebwohl M, Feely M, Kronbergs A, Eberhart N, Zhu D, Inman E, Grace E, Holzkaemper T, Rahman P, Marzo-Ortega H, Papp KA, Merola JF, Gottlieb AB, Schwartzman S.
Deodhar A, et al. Among authors: holzkaemper t.
Arthritis Res Ther. 2024 Feb 12;26(1):49. doi: 10.1186/s13075-023-03257-7.
Arthritis Res Ther. 2024.
PMID: 38347650
Free PMC article.
Item in Clipboard
Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis.
Augustin M, Mrowietz U, Willsmann-Theis D, Gerdes S, Fotiou K, Schuster C, Mert C, Holzkaemper T, Behrens F, Pinter A.
Augustin M, et al. Among authors: holzkaemper t.
J Dtsch Dermatol Ges. 2024 Feb;22(2):278-281. doi: 10.1111/ddg.15292. Epub 2024 Jan 7.
J Dtsch Dermatol Ges. 2024.
PMID: 38185772
No abstract available.
Item in Clipboard
Cite
Cite